Coming Soon: FDA Guidance on Regulation of Clinical Decision Support (CDS) Apps Bradley Merrill ThompsonIn this 1-minute audio snippet, Bradley Merrill Thompson, Member of the Firm at Epstein Becker & Green and General Counsel to the mHealth Regulatory Coalition, warns of FDA mobile guidance that the drug industry should be concerned about: new guidelines regarding FDA’s regulation of clinical decision support (CDS) software.

Your browser does not support the audio element. Upgrade your browser to one that does

Other resources: